PD-1 Inhibition in Advanced Myeloproliferative Neoplasms

Clinical trial NCT03065400 · COMPLETED

Trial details

NCT number: NCT03065400
Sponsor: John Mascarenhas
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Phase Myelofibrosis Primary Myelofibrosis Post-essential Thrombocythemia Myelofibrosis Polycythemia Vera

Start date: 2017-06-14
Primary completion: 2020-05-28
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.